Clinical Trial Update: Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating xenon inhalation as a neuroprotective treatment for ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Xenon (xenon)

Snippet

Sponsor: Negovsky Reanimatology Research Institute | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED